triple-hormone-receptor agonist retatrutide for obesity Triple Hormone Receptor Agonist: Mechanism, Evidence, and UK Status – Bolt Pharmacy What Is Retatrutide (RETA)? The
Description
Patients currently on semaglutide who have hit a weight loss plateau often see renewed progress when transitioning to tirzepatide, likely due to the additional GIP receptor activation
Contraindicated Combinations Using Retatrutide with other GLP-1 based medications is not recommended
Common reasons include concerns about side effects, cost, medication access, and a preference for gradual changes
Know your milligram target before touching a syringe
But as with any powerful medication, that added effectiveness comes with trade-offs
12 mg weekly (advanced/aggressive)
